The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Tritylcysteine     2-amino-3-tritylsulfanyl- propanoic acid

Synonyms: SureCN768202, ACMC-2097c0, NSC-83265, Neuro_000036, NSC-124663, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on NSC83265

 

Biological context of NSC83265

 

Associations of NSC83265 with other chemical compounds

  • We show here that S-trityl-l-cysteine and monastrol both bind to the same region on Eg5 by induced fit in a pocket formed by helix alpha3-strand beta5 and loop L5-helix alpha2, and both inhibitors trigger similar local conformational changes within the interaction site [2].
  • Among the 10 compounds tested, only SAMC, diallyl disulfide (DADS), and S-trityl-L-cysteine (trityl-cys) cause significant inhibition of cell growth with IC(50) values of 150, 56, and 0.9 micromol/L, respectively [5].
 

Gene context of NSC83265

References

  1. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression. Skoufias, D.A., DeBonis, S., Saoudi, Y., Lebeau, L., Crevel, I., Cross, R., Wade, R.H., Hackney, D., Kozielski, F. J. Biol. Chem. (2006) [Pubmed]
  2. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5. Brier, S., Lemaire, D., Debonis, S., Forest, E., Kozielski, F. Biochemistry (2004) [Pubmed]
  3. In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities. DeBonis, S., Skoufias, D.A., Lebeau, L., Lopez, R., Robin, G., Margolis, R.L., Wade, R.H., Kozielski, F. Mol. Cancer Ther. (2004) [Pubmed]
  4. Regulation and targeting of Eg5, a mitotic motor protein in blast crisis CML: overcoming imatinib resistance. Carter, B.Z., Mak, D.H., Shi, Y., Schober, W.D., Wang, R.Y., Konopleva, M., Koller, E., Dean, N.M., Andreeff, M. Cell Cycle (2006) [Pubmed]
  5. Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Xiao, D., Pinto, J.T., Gundersen, G.G., Weinstein, I.B. Mol. Cancer Ther. (2005) [Pubmed]
 
WikiGenes - Universities